THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) Stock Price, Quote, News & History

TTIPFOTCQX

Trade with Public

$0.4200

At close: Jul 17, 5:00 PM EST

OverviewShort Interest

Key Statistics

Open

Volume / Avg.

0 / 17.62K

Day Range

- - -

52 Wk Range

0.36 - 0.58

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Thiogenesis Therapeutics Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.91M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-5.91M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.10M

Valuation Metrics

Enterprise Value

$20.18M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-23.48%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$903.46K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 17.62K

Day Range

- - -

52 Wk Range

0.36 - 0.58

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Thiogenesis Therapeutics Corp is a clinical-stage biotechnology company developing TTI-0102, a novel controlled-release cysteamine prodrug designed to improve tolerability and dosing relative to existing therapies. The Company is focused on TTI-0102 ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) stock?

You can purchase shares of THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (OTCQX:TTIPF) through any online brokerage.

View our list of the best stock brokerages

Who are THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) competitors?

There are no as such competitors for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..

What is the forecast, or price target, for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) stock?

There is no analysis for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. to provide a consensus price target.

What is the current price for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF)?

The stock price for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (OTCQX: TTIPF) is $0.42 last updated June 5, 2026 at 11:27 AM EDT.

Does THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) pay a dividend?

There are no upcoming dividends for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..

When is THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (OTCQX:TTIPF) reporting earnings?

THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. does not have any upcoming earnings scheduled.

Is THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) going to split?

There is no upcoming split for THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp..

What sector and industry does THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. (TTIPF) operate in?

THIOGENESIS THERAPEUTICS by Thiogenesis Therapeutics Corp. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQX.